Vaccinia fetalis, the vertical transfer of vaccinia virus from mother to fetus, is a relatively rare but often fatal complication of primary vaccinia virus vaccination during pregnancy. To date there has been no attempt to develop an animal model to study the pathogenesis of this acute viral infection in vivo. Here we report that infection of gestating BALB/c mice by either intravenous or intraperitoneal routes with the Western Reserve strain of vaccinia virus results in the rapid colonization of the placenta and vertical transfer of virus to the developing fetus. Systemic maternal infections during gestation lead to the death of all offspring prior to or very shortly after birth. Using in situ hybridization for vaccinia virus mRNA to identify infected cells, we show that the virus initially colonizes cells lining maternal lacunae within the trophospongium layer of the placenta. The study of this model will significantly enhance our understanding of the pathogenesis of fetal vaccinia virus infections and aid in the development of effective treatments designed to reduce the risk of vaccinia virusassociated complications during pregnancy.Vaccinia virus, the prototypical member of the Orthopoxvirus genus and a close relative of smallpox (variola) virus, was the live viral vaccine used in the global variola eradication campaign (8, 9). The recent decision to begin vaccinating civilian health care workers against smallpox and the outbreak of monkeypox in the American Midwest have renewed interest in the pathogenesis of acute poxvirus infections. According to present medical standards, vaccinia virus has a relatively poor safety profile and has the capacity to cause severe complications in pregnant women, very young children, and other immunocompromised individuals. An estimated 15 to 50 people/ million who receive primary vaccinia virus vaccinations will experience potentially life-threatening side effects including allergic reactions at the site of vaccination, spread of the virus to other parts of the body, and infection of the central nervous system (6). The potential for vaccine-associated complications has led the U.S. advisory committee on immunization practices to recommend that infants under 1 year of age and adults with weakened immune systems or those with preexisting skin conditions such as eczema or atopic dermatitis not be routinely vaccinated in the absence of clear exposure to either smallpox or monkeypox (3). In addition, the advisory committee has also recommended against vaccinating pregnant women or women who are attempting to become pregnant due to the potential for vertical transmission of vaccinia virus from mother to fetus (3,4,30). Currently there have been fewer than 50 documented cases in the medical literature of vertical transfer of vaccinia virus during pregnancy, most of which resulted in the death of the affected offspring (11-13, 20, 21, 29). Unfortunately our knowledge of the pathological consequences of vaccinia virus infections during pregnancy has been limited by the lack of an app...